Ryan Zimmerman
Stock Analyst at BTIG
(4.26)
# 355
Out of 4,873 analysts
175
Total ratings
54.05%
Success rate
13.06%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMED Globus Medical | Downgrades: Neutral | n/a | $58.46 | - | 12 | May 27, 2025 | |
| VCEL Vericel | Maintains: Buy | $56 → $66 | $42.22 | +56.32% | 8 | Nov 26, 2024 | |
| PEN Penumbra | Maintains: Buy | $232 → $270 | $252.33 | +7.00% | 19 | Nov 26, 2024 | |
| GKOS Glaukos | Maintains: Buy | $140 → $149 | $99.14 | +50.29% | 10 | Nov 26, 2024 | |
| ISRG Intuitive Surgical | Maintains: Buy | $535 → $561 | $522.71 | +7.33% | 17 | Nov 26, 2024 | |
| SYK Stryker | Maintains: Buy | $383 → $394 | $391.00 | +0.77% | 15 | Oct 30, 2024 | |
| HUMA Humacyte | Reiterates: Buy | $10 | $2.17 | +361.89% | 4 | Oct 18, 2024 | |
| ALC Alcon | Maintains: Buy | $104 → $106 | $87.47 | +21.19% | 11 | Oct 14, 2024 | |
| IART Integra LifeSciences Holdings | Upgrades: Neutral | n/a | $11.90 | - | 6 | Oct 7, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Buy | $134 → $126 | $92.83 | +35.73% | 7 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $72.48 | +37.97% | 2 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $74.58 | - | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $73 | $13.40 | +444.78% | 4 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $16.73 | +216.80% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $3 | $0.62 | +383.71% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.86 | - | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.78 | - | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $2.15 | +86.05% | 1 | Jan 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $3.61 | +66.20% | 6 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.21 | - | 3 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $59 → $52 | $21.72 | +139.41% | 7 | Oct 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $10.88 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $10.27 | +172.64% | 4 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $169.01 | +18.34% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $304.82 | +14.82% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $130 | $138.24 | -5.96% | 3 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $58.15 | - | 1 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $86.15 | +48.58% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $12.52 | +19.81% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $91 | $64.21 | +41.72% | 1 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $19.53 | +115.05% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $5.33 | +884.99% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $10.26 | - | 3 | Apr 2, 2020 |
Globus Medical
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $58.46
Upside: -
Vericel
Nov 26, 2024
Maintains: Buy
Price Target: $56 → $66
Current: $42.22
Upside: +56.32%
Penumbra
Nov 26, 2024
Maintains: Buy
Price Target: $232 → $270
Current: $252.33
Upside: +7.00%
Glaukos
Nov 26, 2024
Maintains: Buy
Price Target: $140 → $149
Current: $99.14
Upside: +50.29%
Intuitive Surgical
Nov 26, 2024
Maintains: Buy
Price Target: $535 → $561
Current: $522.71
Upside: +7.33%
Stryker
Oct 30, 2024
Maintains: Buy
Price Target: $383 → $394
Current: $391.00
Upside: +0.77%
Humacyte
Oct 18, 2024
Reiterates: Buy
Price Target: $10
Current: $2.17
Upside: +361.89%
Alcon
Oct 14, 2024
Maintains: Buy
Price Target: $104 → $106
Current: $87.47
Upside: +21.19%
Integra LifeSciences Holdings
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $11.90
Upside: -
Zimmer Biomet Holdings
Oct 3, 2024
Maintains: Buy
Price Target: $134 → $126
Current: $92.83
Upside: +35.73%
Sep 18, 2024
Upgrades: Buy
Price Target: $100
Current: $72.48
Upside: +37.97%
Sep 5, 2024
Initiates: Neutral
Price Target: n/a
Current: $74.58
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $72 → $73
Current: $13.40
Upside: +444.78%
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $16.73
Upside: +216.80%
May 16, 2024
Maintains: Buy
Price Target: $2 → $3
Current: $0.62
Upside: +383.71%
May 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.86
Upside: -
Apr 11, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.78
Upside: -
Jan 23, 2024
Initiates: Buy
Price Target: $4
Current: $2.15
Upside: +86.05%
Dec 27, 2023
Maintains: Buy
Price Target: $4 → $6
Current: $3.61
Upside: +66.20%
Nov 14, 2023
Downgrades: Neutral
Price Target: n/a
Current: $8.21
Upside: -
Oct 4, 2023
Maintains: Buy
Price Target: $59 → $52
Current: $21.72
Upside: +139.41%
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $10.88
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $27 → $28
Current: $10.27
Upside: +172.64%
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $169.01
Upside: +18.34%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $304.82
Upside: +14.82%
Apr 17, 2023
Maintains: Buy
Price Target: $125 → $130
Current: $138.24
Upside: -5.96%
Oct 31, 2022
Initiates: Neutral
Price Target: n/a
Current: $58.15
Upside: -
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $86.15
Upside: +48.58%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $12.52
Upside: +19.81%
Feb 22, 2021
Maintains: Buy
Price Target: $84 → $91
Current: $64.21
Upside: +41.72%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $19.53
Upside: +115.05%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $5.33
Upside: +884.99%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $10.26
Upside: -